Insider Trading Activity HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) – Major Shareholder Sold 1,149,813 shares of Stock

Insider Trading Activity For HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)

Holdings A/S Novo , Major Shareholder of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) reportedly Sold 1,149,813 shares of the company’s stock at an average price of 1.81 for a total transaction amount of $2,081,161.53 SEC Form

Insider Trading History For HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)

On 5/11/2015 A/S Novo, Major Shareholder, bought 365,106 with an average share price of $14.00 per share and the total transaction amounting to $5,111,484.00.View SEC Filing

On 8/11/2015 John L Lubniewski, Insider, bought 5,000 with an average share price of $7.67 per share and the total transaction amounting to $38,350.00.View SEC Filing

On 8/18/2015 Patrick C. Roche, SVP, bought 6,500 with an average share price of $5.76 per share and the total transaction amounting to $37,440.00.View SEC Filing

On 8/24/2015 Debra A Gordon, VP, bought 1,000 with an average share price of $5.16 per share and the total transaction amounting to $5,160.00.View SEC Filing

On 3/9/2016 Tim B Johnson, CEO, sold 6,299 with an average share price of $2.69 per share and the total transaction amounting to $16,944.31.View SEC Filing

On 3/9/2016 Shaun D Mcmeans, CFO, sold 3,325 with an average share price of $2.69 per share and the total transaction amounting to $8,944.25.View SEC Filing

On 3/9/2016 Patrick C Roche, SVP, sold 3,491 with an average share price of $2.69 per share and the total transaction amounting to $9,390.79.View SEC Filing

Analyst Ratings For HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)
These are 1 Hold Rating, 2 Buy Ratings .
The current consensus rating for HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) is Buy (Score: 2.67) with a consensus target price of $6.17 , a potential (224.56% upside)

Analyst Ratings History For HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)

• On 3/28/2016 Leerink Swann Reiterated Rating Outperform with a price target of $10.00 to $5.00
• On 4/19/2017 Canaccord Genuity Boost Price Target of rating Hold with a price target of $5.50 to $6.50
• On 5/16/2017 Rodman & Renshaw Boost Price Target of rating Buy to Buy with a price target of $4.50 to $6.00
• On 8/9/2017 HC Wainwright Set Price Target of rating Buy with a price target of $6.00

Recent Trading Activity for HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)
Shares of HTG Molecular Diagnostics, Inc. closed the previous trading session at 1.90 down -0.09 -4.52% with 1,173,177 shares trading hands.